Where Global Innovation
and Capital Meet
LIVE

Flotation/IPO

Daily Deal Round Up: May 6, 2022

The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

May 6, 2022

HilleVax racks up $200m in its IPO

The Takeda Vaccines spinoff floated in an upsized offering that granted its former parent $100m in shares.

May 3, 2022

Daily Deal Round Up: April 27, 2022

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

Apr 27, 2022

GemPharmatech gets $175m in initial public offering

The Sinopharm-backed laboratory animal model developer floated on Shanghai Stock Exchange’s Star Market two years after its last equity funding.

Apr 26, 2022

Deezer agrees $1.1bn reverse merger

The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.

Apr 20, 2022

Hinova implements $166m IPO

Tigermed, Fosun, Haisco and Sinopharm-CICC all scored exits as the oncology and metabolic disorder therapeutics went public in China.

Apr 14, 2022

HilleVax to attack public markets

The Takeda spinoff is developing a vaccine for acute gastroenteritis caused by norovirus infection, and raised about $140m in August 2021.

Apr 11, 2022

Microba makes tracks to ASX

The Macrogen-backed gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.

Apr 6, 2022

Other News

RecBio delivers IPO

The China Resources and Legend Holdings-backed vaccine technology developer floated in Hong Kong in a $97.7m offering following nearly $460m in funding.

Apr 5, 2022

Daily Deal Round Up: March 29, 2022

DigitalBridge Ventures led wireless adoption software developer Celona's $60m series C round while Papaya is paying up to $200m for Rakuten-backed payment platform developer Azimo.

Mar 29, 2022

GoTo gets $1.1bn in initial public offering

The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.

Mar 29, 2022

AN2 Therapeutics prices $69m IPO

The Brii Biosciences-backed lung disease treatment developer priced an upsized offering in the middle of its range.

Mar 29, 2022

Hub Cyber Security organises $1.28bn reverse merger

The Axa-backed cybersecurity software provider is set to list through a tie-up with Mount Rainier Acquisition Corp.

Mar 25, 2022

Moi moves towards public listing

The KDDI and Sinar Mas-backed video streaming platform developer is scheduled to float on the Tokyo Stock Exchange’s Growth Market on April 27 at a valuation of approximately $51m.

Mar 24, 2022

Editor's Picks

Deezer agrees $1.1bn reverse merger

The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.

Apr 20, 2022

GoTo gets $1.1bn in initial public offering

The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.

Mar 29, 2022

GoTo targets $1.1bn in initial public offering

More than 20 corporate backers are due to score exits through an offering that could value the online consumer services portal at nearly $29bn.

Mar 15, 2022

Perfect permits billion-dollar reverse merger

The corporate-backed virtual cosmetics app developer’s SPAC merger later this year is set to be boosted by $50m in financing from investors including CyberLink, Chanel, Shiseido and Snap.

Mar 4, 2022
© 2021 Mawsonia Ltd. All rights reserved.
test reg

Login